• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[在存在其他抗菌药物的情况下,通过微生物学方法测定血清氨基糖苷类药物和万古霉素浓度]

[Determination of serum aminoglycoside and vancomycin concentrations by the microbiological method in the presence of other antimicrobials].

作者信息

Corso A, Galas M F, Rossi M A

机构信息

Instituto Nacional de Microbiología Dr. Carlos Malbrán, Buenos Aires, Argentina.

出版信息

Rev Argent Microbiol. 1996 Jul-Sep;28(3):123-31.

PMID:9026822
Abstract

The determination of serum concentrations of antimicrobials with a narrow therapeutic range by microbiological method requires some modifications when the patient is under combined antimicrobial therapy. The methodological conditions for the appraisal of aminoglycosides and vancomycin in the presence of other drugs were evaluated by using strains with selective sensitivity to the antimicrobial to be tested or by the adding crude extracts of beta-lactamases for the inactivation of the beta-lactam antimicrobials. These beta-lactamases were obtained from Enterobacter cloacae P99 (derepressed mutant) cultures for the inactivation of penicillins and first, second and third generation cephalosporins, as well as from Stenotrophomonas (Xanthomonas) maltophilia M 1484 cultures for the hydrolysis of imipenem. The strains allowing vancomycin appraisal and indifferent to the synergic activity of other drugs in the mixture were S. aureus M 2120, when the accompanying antimicrobials were gentamicin, ciprofloxacin or rifampicin, and E. faecalis M 2113, E. avium M 2091 and S. aureus M 2101 when the drugs in the mixture were amikacin, lincomycin or trimethoprim-sulfamethoxazole, respectively. For the appraisal of gentamicin in the presence of vancomycin or fluoroquinolones (ciprofloxacin or norfloxacin), E. coli M 1376 was the most suitable strain, while the use of K. pneumoniae ATCC 10031 was required for the appraisal of amikacin or netilmicin. When rifampicin was the accompanying antimicrobial, E. coli M 1495 turned out more adequate. E. coli M 1462 proved to be more satisfactory for gentamicin, amikacin and netilmicin dosages in samples also containing chloramphenicol, trimethoprim-sulfamethoxazole or tetracycline.

摘要

当患者接受联合抗菌治疗时,采用微生物学方法测定治疗窗窄的抗菌药物的血清浓度需要做一些调整。通过使用对被测抗菌药物具有选择性敏感性的菌株,或添加β-内酰胺酶粗提物使β-内酰胺类抗菌药物失活,来评估在其他药物存在的情况下氨基糖苷类和万古霉素的方法学条件。这些β-内酰胺酶分别从阴沟肠杆菌P99(去阻遏突变体)培养物中获得,用于使青霉素及第一、二、三代头孢菌素失活;从嗜麦芽窄食单胞菌(嗜麦芽黄单胞菌)M 1484培养物中获得,用于使亚胺培南水解。当混合使用的其他药物为庆大霉素、环丙沙星或利福平,允许评估万古霉素且对混合物中其他药物的协同活性无影响的菌株是金黄色葡萄球菌M 2120;当混合物中的药物分别为阿米卡星、林可霉素或甲氧苄啶-磺胺甲恶唑时,允许评估万古霉素的菌株是粪肠球菌M 2113、鸟肠球菌M 2091和金黄色葡萄球菌M 2101。对于在万古霉素或氟喹诺酮类药物(环丙沙星或诺氟沙星)存在的情况下评估庆大霉素,大肠杆菌M 1376是最合适的菌株;而评估阿米卡星或奈替米星则需要使用肺炎克雷伯菌ATCC 10031。当伴随使用的抗菌药物为利福平时,大肠杆菌M 1495更适用。对于还含有氯霉素、甲氧苄啶-磺胺甲恶唑或四环素的样品中庆大霉素、阿米卡星和奈替米星的剂量测定,大肠杆菌M 1462被证明更令人满意。

相似文献

1
[Determination of serum aminoglycoside and vancomycin concentrations by the microbiological method in the presence of other antimicrobials].[在存在其他抗菌药物的情况下,通过微生物学方法测定血清氨基糖苷类药物和万古霉素浓度]
Rev Argent Microbiol. 1996 Jul-Sep;28(3):123-31.
2
Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.印度一家三级护理医院中大肠杆菌和肺炎克雷伯菌的流行表型及抗生素耐药性:质粒介导的头孢西丁耐药性
Int J Infect Dis. 2008 May;12(3):256-64. doi: 10.1016/j.ijid.2007.08.008. Epub 2007 Nov 5.
3
[Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].[使用表型和基因型标准评估水生阴沟肠杆菌菌株中的β-内酰胺耐药性]
Bacteriol Virusol Parazitol Epidemiol. 2002 Jul-Dec;47(3-4):185-91.
4
[Drug resistance of 100 clinical strains of Enterococcus spp].[100株临床分离肠球菌属细菌的耐药性]
Med Dosw Mikrobiol. 1999;51(3-4):239-47.
5
[Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].肺炎克雷伯菌和大肠杆菌分离株中的超广谱β-内酰胺酶
Zhonghua Yi Xue Za Zhi. 2002 Nov 10;82(21):1476-9.
6
Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.从伊斯坦布尔大学医院血培养物中分离出的产超广谱β-内酰胺酶大肠埃希菌和肺炎克雷伯菌的患病率及抗菌药物耐药模式
Chemotherapy. 2009;55(4):293-7. doi: 10.1159/000224657. Epub 2009 Jun 10.
7
Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.产超广谱β-内酰胺酶(ESBL)和不产该酶的肺炎克雷伯菌菌株对选定非β-内酰胺类抗生素的耐药性。
Med Sci Monit. 2002 Mar;8(3):BR100-4.
8
Antibiotic use in neonatal sepsis.新生儿败血症中的抗生素使用。
Turk J Pediatr. 1998 Jan-Mar;40(1):17-33.
9
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.头孢洛林(PPI-0903M,T-91825)对具有明确耐药机制和表型的细菌的体外活性。
J Antimicrob Chemother. 2007 Aug;60(2):300-11. doi: 10.1093/jac/dkm150. Epub 2007 Jun 4.
10
Prevalence of high level aminoglycoside and vancomycin resistance among enterococci in Turkey.土耳其肠球菌中高水平氨基糖苷类和万古霉素耐药性的流行情况。
Acta Microbiol Pol. 1998;47(3):267-73.